ADVANCED MALIGNANCIES
Clinical trials for ADVANCED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug BR105 tested in 31 patients – study halted early
Disease control TerminatedThis early-stage study tested an experimental drug called BR105 in 31 adults with advanced cancers that no longer responded to standard treatments. The main goals were to check the drug's safety, find the best dose, and see if it could shrink tumors. The study was stopped early, …
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Cancer cocktail study halted: early hopes dashed for Triple-Drug combo
Disease control TerminatedThis study tested a combination of three drugs (azacitidine, pembrolizumab, and epacadostat) in people with advanced solid tumors, including lung and colorectal cancers that had stopped responding to standard treatments. The goal was to see if the combination was safe and could s…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 12, 2026 13:43 UTC